JCI Editorial Board potential conflicts of interest

See JCI Insight's conflict-of-interest policy

First tier

AGTC (D. Martin)

Akadium Life Sciences (S.M. Day)

Gilead (D.A. Fox)

Lycera (W. Zou)

Millendo Therapeutics (A. Tai)

MIYARISAN Pharmaceutical Co. Ltd. (N. Kamada)

NGM (W. Zou)

Opsidio LLC (N.W. Lukacs)

Regeneron (D.A. Fox)

Synlogic Therapeutics (W. Zou)